NEWS & EVENTS

Inotrem appoints Laurent Vincens as Chief Technology Officer and Head of Manufacturing

Paris, March 17, 2022. Inotrem, an advanced clinical stage biotech company specialized in immunotherapies for acute and chronic inflammatory syndromes, announced today the appointment of Laurent Vincens as Chief Technology Officer and Head of Manufacturing. The newly created position comes as the company is rapidly advancing its TREM-1 pathway focused drug development programs.

Read full article (PDF)